Under healthy conditions, the PD-1/PD-L1 pathway maintains host immune homeostasis, while under inflammatory conditions, interactions between PD-1 and its ligand PD-L1 serve to inhibit T cell responses, which protects the lesion from hyperactivated T cells in cancer [37]. The gene discussed is PDCD1; the disease is cancer.